Experience of research nurses with oral encochleated amphotericin B for treatment of cryptococcal meningitis in a resource-limited setting
Abstract Background Besides the commonly used intravenous formulations of amphotericin B, an oral nanocrystal amphotericin B (MAT2203) formulation is being evaluated for efficacy to treat invasive fungal infections. This new experimental oral formulation has not been used before. Methods Herein, we...
Saved in:
| Main Authors: | Cynthia Ahimbisibwe, Richard Kwizera, Jane Frances Ndyetukira, Olivie Carolyne Namujju, Alisat Sadiq, Mucunguzi Atukunda, Caleb P. Skipper, David R. Boulware, David B. Meya |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Infectious Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12879-025-11319-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reflexed cryptococcal antigenaemia detection rates in the Western Cape, South Africa
by: Naseem Cassim, et al.
Published: (2025-04-01) -
An unusual clinical presentation of Cryptococcal meningitis: The importance of a detailed history and physical
by: Shay Nakahira, et al.
Published: (2025-01-01) -
Comparative efficacy and tolerability of amphotericin B lipid complex and liposomal amphotericin B in the treatment of invasive fungal infections in patients with hematological malignancies: literature review
by: N. V. Dmitrieva, et al.
Published: (2014-07-01) -
Comparing the Performance of Two Cryptococcal Antigen Detection Tests: Chemiluminescence vs Colloidal Gold Methods
by: Yu XY, et al.
Published: (2024-12-01) -
Profile and acute mortality outcome of patients admitted with cryptococcal meningitis to an urban district hospital in KwaZulu-Natal, South Africa
by: Benjamin O. Adeyemi, et al.
Published: (2015-04-01)